5HB.F Shanghai Haohai Biological Technology Co. Ltd

Healthcare Biotechnology Frankfurt Exchange
11.69 EUR
Close of Nov 12, 2026
1.63 2.87
Market cap
EUR 394M
P/E
22.0x
P/B
0.56x
ROE
4.6%
Dividend yield
6.27%
Fundamental score
-

Ratios use the latest price and the fiscal year ending Dec 2025.

Is 5HB.F undervalued?

Graham number
Price11.69
Graham value15.83
Discount26.2%

5HB.F trades 26.2% below its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Shanghai Haohai Biological Technology Co. Ltd fundamental analysis

No fundamental analysis for Shanghai Haohai Biological Technology Co. Ltd yet.

Shanghai Haohai Biological Technology Co. Ltd stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Shanghai Haohai Biological Technology Co. Ltd

Shanghai Haohai Biological Technology Co., Ltd. engages in the research, development, manufacture, and sale of biomedical materials in Mainland China, Europe, the United States, and internationally. The company offers ophthalmic implants, assistive devices, and medical devices; medical optical instruments, including intraocular lenses, endoscopic equipment, ophthalmic surgical instruments, and other ophthalmic medical products; hyaluronic acid and chitosan; and electronic in…

Full company profile